United Health Products Advances FDA Approval Process for Novel Hemostatic Agent
Medical device company United Health Products has made significant progress in its FDA approval process for CelluSTAT, a natural bleeding control agent, while securing funding and pursuing an uplisting to OTCQB. The development could lead to a new option in surgical bleeding control.
